首页> 外文期刊>Genetic testing and molecular biomarkers >Polymorphisms Involved in Folate Metabolism Pathways and the Risk of the Development of Childhood Acute Leukemia
【24h】

Polymorphisms Involved in Folate Metabolism Pathways and the Risk of the Development of Childhood Acute Leukemia

机译:叶酸代谢途径的多态性与儿童急性白血病发展的风险

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives: Polymorphisms that reduce the activity of reduced folate carrier (RFC) and methylenetetrahydrofolate reductase (MTHFR) and double (2R2R) or triple (3R3R) 28-bp tandem repeats in the promoter region of thy-midylate synthase (TS) have been associated with the risk of childhood acute leukemia (AL). A case-control genotyping study was conducted in Brazilian children with the aim of investigating RFC, MTHFR, and TS polymorphisms as risk factors. Methods: The polymerase chain reaction-restriction fragment length polymor-phism method was employed in 177 AL cases and 390 controls. Results: The presence of the mutant 1298C, also RFC 80A, was linked to a decreased risk of developing acute lymphoid leukemia (ALL) (odds ratio (OR) = 0.46, 95% confidence interval (CI) = 0.30-071 and OR = 0.51, 95% CI = 0.28-0.0.93, respectively). Conclusions: The genotype 677 CT was associated with increased risk of developing ALL (OR = 1.6, 95% CI = 1.1-2.7). Further epidemiological study is needed to unravel the role of complex multiple gene-environment interactions in leukemogenesis.
机译:目标:多态性与降低还原的叶酸载体(RFC)和亚甲基四氢叶酸还原酶(MTHFR)的活性以及在胸腺嘧啶合酶(TS)的启动子区域中的双(2R2R)或三(28R)串联重复序列的28 bp相关。有儿童急性白血病(AL)的风险。在巴西儿童中进行了一项病例对照基因分型研究,目的是调查RFC,MTHFR和TS多态性作为危险因素。方法:对177例AL患者和390例对照者采用聚合酶链反应-限制性片段长度多态性法。结果:突变体1298C以及RFC 80A的存在与发生急性淋巴性白血病(ALL)的风险降低相关(比值比(OR)= 0.46,95%置信区间(CI)= 0.30-071并且OR =分别为0.51、95%CI = 0.28-0.0.93)。结论:基因型677 CT与发生ALL的风险增加相关(OR = 1.6,95%CI = 1.1-2.7)。需要进一步的流行病学研究来阐明复杂的多基因-环境相互作用在白血病发生中的作用。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2013年第2期|147-152|共6页
  • 作者单位

    Departamento de Genetica, Universidade Federal de Pernambuco, Recife, Brazil Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil;

    Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas, Universidade de Pernambuco, Recife, Brazil;

    Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas, Universidade de Pernambuco, Recife, Brazil;

    Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas, Universidade de Pernambuco, Recife, Brazil;

    Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas, Universidade de Pernambuco, Recife, Brazil;

    Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas, Universidade de Pernambuco, Recife, Brazil;

    Instituto Nacional de Cancer, Rio de Janeiro, Brazil;

    Departamento de Genetica, Universidade Federal de Pernambuco, Recife, Brazil Centro de Onco-Hematologia, Hospital Universitario Oswaldo Cruz, Recife, Brazil Instituto de Ciencias Biologicas Universidade de Pernambuco Rua Arnobio Marques 310 Santo Amaro Recife 50100-130 Pernambuco Brazil;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:17:38

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号